Gender Male
Investor Type
Mr. Krupik is the chief executive officer for CBI and responsible for defining the vision, strategy and direction of CBI.
Mr. Krupik is an active chairman at D-pharm, CureTech, Mediwound and Andromeda.
An accomplished, multi-disciplinary industry executive and visionary, Mr. Krupik was a key driver in the launch of numerous successful
companies in the fields of medical technology (Given Imaging, Galil Medical), image processing (3DV), broadband and software. With a wide-ranging entrepreneurial track record, he is well versed in the complex processes and aspects of transforming promising ideas into thriving companies.
A master of the art of harnessing investment capital to technology in order to weave commercial achievements, Mr. Krupik was highly instrumental in the foundation of Rafael Development Corporation (RDC), a joint venture of Rafael (a technological division of the Israeli Ministry of Defense) and a group of large investment corporations. He served as president and CEO of RDC, which specializes in identifying commercially viable technologies within Rafael and forming start-up companies around them.
Mr. Krupik held several senior positions at Tadiran Telecommunication Group where he accrued extensive experience in high-tech management.
Ruben holds an LLB from the Faculty of Law of the Tel Aviv University and B.A.s in economics and political science both from the Hebrew University of Jerusalem.
